Observational studyBMJ open2022

Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study.

Ashley Jaksa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.